Detalhe da pesquisa
1.
NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024.
J Natl Compr Canc Netw
; 21(10): 1000-1010, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37856201
2.
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 19(1): 77-102, 2021 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33406487
3.
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.
J Natl Compr Canc Netw
; 18(4): 380-391, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32259785
4.
Breadth of Genetic Testing Selected by Patients at Risk of Hereditary Breast and Ovarian Cancer.
Int J Gynecol Cancer
; 28(1): 26-33, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28930807